Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CIRS encompasses two main entities: 1. Centre for Innovation in Regulatory Science: A neutral research organization based in London that advances global pharmaceutical regulation and health technology assessment policies by facilitating collaboration among regulators, HTA agencies, industry leaders, patient groups, and academia. It operates internationally as an independent subsidiary of Clarivate. 2. Chemical Inspection and Regulation Service ("CIRS Group"): A leading product safety and chemical management consulting firm headquartered in Hangzhou, China. It provides comprehensive regulatory compliance services—including testing—for chemicals, cosmetics, medical devices, food products, agrochemicals, pharmaceuticals and more. The group includes specialized subsidiaries such as C&K Testing and CIRS Kexin Biotech. Neither entity develops drugs or has its own clinical pipeline but plays a critical role supporting product development through regulatory strategy/advice/testing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CIRS.